We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Lupus Institute
Colleague Insights
Conferences
Resource Library
Sign in
Join now
featured
Published in Rheumatology and
1 other channel

Journal Scan / Research · May 10, 2022

Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine and Booster in Patients With Autoimmune Rheumatic Diseases

Annals of the Rheumatic Diseases

 

 Save  Recommend
 Share

Additional Info

Annals of the Rheumatic Diseases
BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study
Ann. Rheum. Dis 2022 Apr 13;[EPub Ahead of Print], A Bieber, I Sagy, L Novack, S Brikman, R Abuhasira, S Ayalon, I Novofastovski, M Abu-Shakra, R Mader

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated